IGFBP2 and neoplasm: Subsequent Western blot and immunohistochemistry analyses of the tumor tissues revealed lower expression of E-cadherin and higher expression of N-cadherin and vimentin in response to IGFBP2 overexpression (Fig. 4D, E).